Prostate Cancer Trial, Recruiting NCT05786742 Sponsor: CHU de Quebec-Universite Laval Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT05786742
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with prostate cancer confirmed by a biopsy, specifically a type called adenocarcinoma
  • People whose cancer is at an early stage (T1c or T2), meaning it is contained within or just around the prostate
  • People whose cancer has not been found in nearby lymph nodes, or where lymph nodes have not yet been assessed
  • People whose cancer has not spread to other parts of the body, or where this has not yet been assessed
  • People with a PSA blood test result below 20 ng/ml
  • People whose cancer scores a 6 or 7 on the Gleason scale, which is a measure of how the cancer cells look under a microscope
  • People who are able to sign a written consent form

Who may not be able to join:

  • People under 18 years of age
  • People whose cancer is at a more advanced stage (T3 or T4), meaning it has grown beyond the prostate
  • People whose cancer has spread to nearby lymph nodes (N1)
  • People whose cancer has spread to other parts of the body (M1)
  • People with a PSA blood test result above 20 ng/ml
  • People whose cancer scores 8, 9, or 10 on the Gleason scale
  • People with a urinary symptom score (IPSS) above 20, or who are taking alpha-blocker medications (confirm with trial site)
  • People who have previously had radiotherapy to the pelvic area
  • People with a history of certain autoimmune connective tissue conditions, such as Lupus, Scleroderma, or Dermatomyositis
  • People with a past history of Inflammatory Bowel Disease
  • People who have prosthetic implants in both hips

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Andre-Guy Martin, CHU de Québec

Phone: 14186915264

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
CHU de Quebec-Universite Laval
Registry
ClinicalTrials.gov
Start date
1 April 2014
Est. completion
1 June 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

GU toxicity analysis (CTCAE); GU toxicity analysis (CTCAE); GU toxicity analysis (CTCAE); GU toxicity analysis (CTCAE); GU toxicity analysis (CTCAE); GU toxicity analysis (CTCAE); GU toxicity analysis (CTCAE); GU toxicity analysis (CTCAE); GI toxicity analysis (CTCAE); GI toxicity analysis (CTCAE); GI toxicity analysis (CTCAE); GI toxicity analysis (CTCAE); GI toxicity analysis (CTCAE); GI toxicity analysis (CTCAE); GI toxicity analysis (CTCAE); GI toxicity analysis (CTCAE); urinary toxicity analysis (IPSS); urinary toxicity analysis (IPSS); urinary toxicity analysis (IPSS); urinary toxicity a...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov